NeuroMetrix to Sell Quell Wearable Pain Relief Device on Amazon.
M2 PHARMA-December 8, 2016-NeuroMetrix to Sell Quell Wearable Pain Relief Device on Amazon
(C)2016 M2 COMMUNICATIONS
- US-based medical device maker NeuroMetrix, Inc.'s (NASDAQ: NURO) Quell Wearable Pain Relief device is now available on Amazon Launchpad, the company said.
Amazon Launchpad is a programme that makes it easy for startups to launch, market, and distribute their products to hundreds of m s of Amazon customers across the globe.
The company has worked with over 100 leading venture capital firms, startup accelerators, and crowd-funding platforms to help more than 1,000 startups launch products in the US, UK, China, Germany, France, and Canada.
Quell is designed for people suffering from chronic pain. The wearable device is lightweight and can be worn during the day while active, and at night while sleeping.
It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain.
Quell users can start, stop, and adjust therapy discreetly via the optional Quell Relief app.
The device also offers advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night.
NeuroMetrix is a commercial stage healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 8, 2016|
|Previous Article:||USFDA grants approval to Genentech's Avastin.|
|Next Article:||First "Scarless" Gallbladder Surgery Performed Using Levita Magnetic Surgical System.|